Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
LIBERTA, 6.0 times Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 1 yen
4935 LIBERTA CO.,LTD. 【J-GAAP】
Earnings ReportLIBERTA CO.,LTD. <4935> [TSE Std] announced its financial results after the market closed on February 14th (16:00). The consolidated ordinary profit for the fiscal year ending December 2024 dropped 68.9% from the previous period to 50 million yen. In the fiscal year ending December 2025, the profit is expected to surge 6.0 times the previous term, reaching 300 million yen. This will be the fourth consecutive term of revenue growth.
At the same time, the company has decided to increase the dividend this fiscal year to 10 yen, an increase of 1 yen from the previous fiscal year.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit grew 29.2% from the same period last year, reaching 93 million yen. The operating profit margin improved from 3.0% in the same period last year to 3.9%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 6,638 | 167 | 200 | 114 | 17.8 | 9 | Feb 14, 2023 | J-GAAP |
Dec, 2023 | 7,087 | 172 | 161 | 111 | 18.7 | 9 | Feb 13, 2024 | J-GAAP |
Dec, 2024 | 8,635 | 71 | 50 | -21 | -3.6 | 9 | Feb 14, 2025 | J-GAAP |
YoY | +21.8% | -58.7% | -68.9% | - | - |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 8,400 | 159 | 140 | 74 | 12.4 | 9 | Nov 14, 2024 | J-GAAP |
Dec, 2024 Results | 8,635 | 71 | 50 | -21 | -3.6 | 9 | Feb 14, 2025 | J-GAAP |
Revision Rate | +2.8% | -55.3% | -64.3% | - | - |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 4,180 | -39 | -42 | -62 | -10.5 | 0 | Aug 9, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | 5,094 | 76 | 52 | -11 | -1.8 | 0 | Feb 14, 2025 | J-GAAP |
YoY | +21.9% | - | - | +82.3% | +82.4% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 7,087 | 172 | 161 | 111 | 18.7 | 9 | Feb 13, 2024 | J-GAAP |
Dec, 2024 | 8,635 | 71 | 50 | -21 | -3.6 | 9 | Feb 14, 2025 | J-GAAP |
Dec, 2025 Guidance | 11,000 | 345 | 300 | 161 | 26.9 | 10 | Feb 14, 2025 | J-GAAP |
YoY | +27.4% | +385.9% | +500.0% | - | - |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 2,125 | 64 | 72 | 72 | 12.2 | 3.0 | Feb 13, 2024 | J-GAAP |
Jan - Mar, 2024 | 1,651 | -183 | -181 | -143 | -24.2 | -11.1 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 2,529 | 144 | 139 | 81 | 13.7 | 5.7 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 2,011 | 15 | -1 | -8 | -1.4 | 0.7 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 2,444 | 95 | 93 | 49 | 8.3 | 3.9 | Feb 14, 2025 | J-GAAP |
YoY | +15.0% | +48.4% | +29.2% | -31.9% | -31.9% |
Related Articles
Fantasista, Oct-Dec (1Q) Ordinary Profit Turns to Profit
IRRC, Oct-Dec (2Q) Ordinary Profit Decreases by 49%
MITSUI MATSUSHIMA, The Current Fiscal Year Ordinary Profit Revised Upward by 24%, Dividend Revised Upward by 30 yen
adish, Returning to Profitability This Year
Cytori Cell Research Institute, The Current Fiscal Year Net Income Revised Downward to a Loss, 37% Deficit Against Net Assets, Decides to Continue No Dividend Policy
EnBio Holdings, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 59%, Exceeds Full-Year Plan
Green Monster, First Half Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 70%
Precision System Science, The Current Fiscal Year Ordinary Profit Loss Widened in Downward Revision
OPTORUN, 5% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
4Cs HD, Oct-Dec (1Q) Ordinary Profit Loss Narrows